BAFF, APRIL, TWE-PRIL: Who's who?

Autoimmunity Reviews

Volumn 7, Issue 4, 2008, Pages 267-271

  Daridon, Capucine ^a   Youinou, Pierre ^a   Pers, Jacques Olivier ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

APRIL; BAFF; TWE PRIL

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CELL SURFACE FUSION PROTEIN; HYBRID PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

A PROLIFERATION INDUCING LIGAND GENE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B CELL ACTIVATING FACTOR GENE; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; GENE; GENE MAPPING; PLEIOTROPY; REVIEW; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS GENE;

AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; HUMANS; PROTEIN BINDING; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTORS;

EID: 39449111352     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.05.002     Document Type: Review

References (26)

1. Le Pottier L., Bendaoud B., Dueymes M., Daridon C., Youinou P., Shoenfeld Y., et al. BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer. J Clin Immunol 29 (Mar 2007) [Electronic publication ahead of print]
2. Toubi E., and Shoenfeld Y. BLyS/FAFF: a potential target in the treatment of active systemic lupus erythematosus. Isr Med Assoc J 6 2 (Feb 2004) 99-102
3. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 27 (2002) 19-26
4. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109 (2002) 59-68
5. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 (1999) 1697-1710
6. Hahne M., Kataoka T., Schroter M., Hofmann K., Irmler M., Bodmer J.L., et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188 (1998) 1185-1190
7. Kelly K., Manos E., Jensen G., Nadauld L., and Jones D.A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60 (2000) 1021-1027
8. Pradet-Balade B., Medema J.P., Lopez-Fraga M., Lozano J.C., Kolfschoten G.M., Picard A., et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J 21 (2002) 5711-5720
9. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293 (2001) 2108-2111
10. Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J., et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280 (2005) 7218-7227
11. Baker K.P. BLyS-an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmun Rev 3 (2004) 368-375
12. Rennert P., Schneider P., Cachero T.G., Thompson J., Trabach L., Hertig S., et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 192 (2000) 1677-1684
13. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 (1999) 1747-1756
14. Gavin A.L., Ait-Azzouzene D., Ware C.F., and Nemazee D. DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF. J Biol Chem 278 (2003) 38220-38228
15. Liu Y., Xu L., Opalka N., Kappler J., Shu H.B., and Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 108 (2002) 383-394
16. Karpusas M., Cachero T.G., Qian F., Boriack-Sjodin A., Mullen C., Strauch K., et al. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J Mol Biol 315 (2002) 1145-1154
17. Oren D.A., Li Y., Volovik Y., Morris T.S., Dharia C., Das K., et al., Galperina O., Gentz R., Arnold E. Structural basis of BLyS receptor recognition. Nat Struct Biol 9 (2002) 288-292
18. Shu H.B., Hu W.H., and Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65 (1999) 680-683
19. Tribouley C., Wallroth M., Chan V., Paliard X., Fang E., Lamson G., et al., Pot D., Escobedo J., Williams L.T. Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 380 (1999) 1443-1447
20. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., et al., Kalled S.L., Hess D.M., Serafini B., Aloisi F., Wekerle H., Hohlfeld R., Meinl E. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 201 (2005) 195-200
21. Lopez-Fraga M., Fernandez R., Albar J.P., and Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2 (2001) 945-951
22. Wallweber H.J., Compaan D.M., Starovasnik M.A., and Hymowitz S.G. The crystal structure of a proliferation-inducing ligand, APRIL. J Mol Biol 343 (2004) 283-290
23. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., et al., Qiang F., Gorelik L., Kalled S.L., Acha-Orbea H., Rennert P.D., Tschopp J., Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201 (2005) 1375-1383
24. Browning J.L., Ngam-ek A., Lawton P., DeMarinis J., Tizard R., Chow E.P., et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72 (1993) 847-856
25. Roschke V., Sosnovtseva S., Ward C.D., Hong J.S., Smith R., Albert V., et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J Immunol 169 (2002) 4314-4321
26. Kolfschoten G.M., Pradet-Balade B., Hahne M., and Medema J.P. TWE-PRIL; a fusion protein of TWEAK and APRIL. Biochem Pharmacol 66 (2003) 1427-1432